Breaking barriers in CRC immunotherapy: Cutting-edge advances in personalized peptide vaccine development.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Breaking barriers in CRC immunotherapy: Cutting-edge advances in personalized peptide vaccine development.
- Published In:
- Critical reviews in oncology/hematology, 216, 104967 (2025)
- Authors:
- Huang, Hairuo, Ren, Jianmin, Jiang, Deming, Hu, Shurong, Yu, Qiao, Tang, Bufu, Xu, Pingbo, Liu, Jingwen
- Database ID:
- RPEP-11456
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11456APA
Huang, Hairuo; Ren, Jianmin; Jiang, Deming; Hu, Shurong; Yu, Qiao; Tang, Bufu; Xu, Pingbo; Liu, Jingwen. (2025). Breaking barriers in CRC immunotherapy: Cutting-edge advances in personalized peptide vaccine development.. Critical reviews in oncology/hematology, 216, 104967. https://doi.org/10.1016/j.critrevonc.2025.104967
MLA
Huang, Hairuo, et al. "Breaking barriers in CRC immunotherapy: Cutting-edge advances in personalized peptide vaccine development.." Critical reviews in oncology/hematology, 2025. https://doi.org/10.1016/j.critrevonc.2025.104967
RethinkPeptides
RethinkPeptides Research Database. "Breaking barriers in CRC immunotherapy: Cutting-edge advance..." RPEP-11456. Retrieved from https://rethinkpeptides.com/research/huang-2025-breaking-barriers-in-crc
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.